Adagene ADAG
NASDAQ ADAG
$3.57 -0.12 (-3.25%)
As of: Sep 4, 2026 · 3:57 PM EDT

Adagene (ADAG) Current Leases (2022 - 2026)

Adagene (ADAG) posted quarterly Current Leases of $92.1 billion for Q4 2025, down 34.87% year-over-year from $141.3 billion in Q4 2024, and up 73145921.88% quarter-over-quarter from $125851.0 in Q2 2025.

Analysis

Adagene (ADAG) Current Leases (2022 - 2026) Analysis & Trends

Adagene (ADAG) has reported Current Leases for 4 consecutive years, with $92.1 billion the latest figure, recorded in Q4 2025.

  • In Q4 2025, Current Leases fell 34.87% year-over-year to $92.1 billion; the TTM figure through Dec 2025 stood at $92.1 billion (down 34.87% YoY), while the FY2025 annual figure was $92.1 billion, down 34.87% from the prior year.
  • Current Leases advanced to $92.1 billion in Q4 2025 per ADAG's latest filing, from $125851.0 in the prior quarter.
  • Across five years, Current Leases topped out at $297.1 billion in Q2 2022 and bottomed at $125851.0 in Q2 2025.
  • Historically, Current Leases has averaged $129.7 billion across 4 years, with a median of $146.7 billion in 2022.
  • Annual changes were most pronounced in 2023 — Current Leases increased 28.93% — and 2024, when it plunged 100.0%.
  • Adagene's Current Leases stood at $152.0 billion in 2022, then climbed by 28.93% to $196.0 billion in 2023, then declined by 27.87% to $141.3 billion in 2024, then sank by 34.87% to $92.1 billion in 2025.
  • Business Quant data shows ADAG's Current Leases at $92.1 billion in Q4 2025, $125851.0 in Q2 2025, and $141.3 billion in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Adagene 211.24 Mn 211.24 Mn - 181,733.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 181,733.00
Dec 31, 2025 92,055.00
Jun 30, 2025 125,851.00
Dec 31, 2024 141,341.00
Jun 30, 2024 141,281.00
Dec 31, 2023 195,955.00
Jun 30, 2023 158,859.00
Dec 31, 2022 151,983.00
Jun 30, 2022 297,066.00